{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:19:27Z","timestamp":1790716767262,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.heliyon.2024.e37896","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T03:28:12Z","timestamp":1726198092000},"page":"e37896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in colorectal cancer"],"prefix":"10.1016","volume":"10","author":[{"given":"HuiE.","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e37896_bib1","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.heliyon.2024.e37896_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J. Clin. Oncol. : official journal of the American Society of Clinical Oncology"},{"key":"10.1016\/j.heliyon.2024.e37896_bib3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0140-6736(23)00772-9","article-title":"Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study","volume":"402","author":"Dasari","year":"2023","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.heliyon.2024.e37896_bib4","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1053\/j.gastro.2023.04.029","article-title":"Molecular profiling provides clinical insights into targeted and immunotherapies as well as colorectal cancer prognosis","volume":"165","author":"Guo","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.heliyon.2024.e37896_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ccell.2022.11.013","article-title":"Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer","volume":"41","author":"Teng","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e37896_bib6","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1158\/1078-0432.CCR-19-3728","article-title":"Mismatch repair-deficient rectal cancer and resistance to neoadjuvant chemotherapy","volume":"26","author":"Cercek","year":"2020","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.heliyon.2024.e37896_bib7","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.heliyon.2024.e37896_bib8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1136\/gutjnl-2022-328845","article-title":"Targeting m(6)A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer","volume":"72","author":"Bao","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2024.e37896_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41586-022-05593-1","article-title":"\u03b3\u03b4 T cells are effectors of immunotherapy in cancers with HLA class I defects","volume":"613","author":"de Vries","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e37896_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006481","article-title":"Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL\/4-1BB co-stimulation","volume":"11","author":"Sun","year":"2023","journal-title":"Journal for immunotherapy of cancer"},{"key":"10.1016\/j.heliyon.2024.e37896_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120320","article-title":"KIR2DL4 promotes the proliferation of RCC cell associated with PI3K\/Akt signaling activation","volume":"293","author":"Ding","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.heliyon.2024.e37896_bib12","article-title":"Roles of HLA-G\/KIR2DL4 in breast cancer immune microenvironment","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37896_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41392-021-00629-w","article-title":"Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab","volume":"6","author":"Zheng","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e37896_bib14","doi-asserted-by":"crossref","first-page":"D1184","DOI":"10.1093\/nar\/gkab860","article-title":"CTR-DB, an omnibus for patient-derived gene expression signatures correlated with cancer drug response","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic acids research"},{"key":"10.1016\/j.heliyon.2024.e37896_bib15","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/jnci\/djac054","article-title":"Lower exome sequencing coverage of ancestrally african patients in the cancer Genome atlas","volume":"114","author":"Wickland","year":"2022","journal-title":"J. Natl. Cancer Inst. (Bethesda)"},{"key":"10.1016\/j.heliyon.2024.e37896_bib16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.heliyon.2024.e37896_bib17","first-page":"Of1","article-title":"Mutation patterns predict drug sensitivity in acute myeloid leukemia","author":"Qin","year":"2024","journal-title":"Clin. Cancer Res. : an official journal of the American Association for Cancer Research"},{"key":"10.1016\/j.heliyon.2024.e37896_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12300","article-title":"Identification of faecal extracellular vesicles as novel biomarkers for the non-invasive diagnosis and prognosis of colorectal cancer","volume":"12","author":"Zhang","year":"2023","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.heliyon.2024.e37896_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ymthe.2023.12.012","article-title":"Irradiated engineered tumor cell-derived microparticles remodel the tumor immune microenvironment and enhance antitumor immunity","volume":"32","author":"Hu","year":"2024","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.heliyon.2024.e37896_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41577-023-00949-8","article-title":"The cancer-immune dialogue in the context of stress","volume":"24","author":"Ma","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37896_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.heliyon.2024.e37896_bib22","article-title":"Fibrosis and cancer: A strained relationship, Biochimica et biophysica acta","volume":"1873","author":"Piersma","year":"2020","journal-title":"Reviews on cancer"},{"key":"10.1016\/j.heliyon.2024.e37896_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-pathol-012615-044438","article-title":"Cancer stem cells: basic concepts and therapeutic implications","volume":"11","author":"Nassar","year":"2016","journal-title":"Annual review of pathology"},{"key":"10.1016\/j.heliyon.2024.e37896_bib24","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e37896_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade2886","article-title":"Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy","volume":"16","author":"Li","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2024.e37896_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115306","article-title":"Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockade","volume":"209","author":"Choi","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2024.e37896_bib27","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41591-024-02813-1","article-title":"Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS\/pMMR colorectal cancer: a randomized phase 2 trial","volume":"30","author":"Wang","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e37896_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1158\/2326-6066.CIR-23-0309","article-title":"Combination of anti-PD-1 and electroacupuncture induces a potent antitumor immune response in microsatellite-stable colorectal cancer","volume":"12","author":"Wang","year":"2024","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.heliyon.2024.e37896_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e37896_bib30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri3064","article-title":"The parallel lives of angiogenesis and immunosuppression: cancer and other tales","volume":"11","author":"Motz","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37896_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2020.103176","article-title":"Possible roles of HLA-G regulating immune cells in pregnancy and endometrial diseases via KIR2DL4","volume":"142","author":"Bai","year":"2020","journal-title":"J. Reprod. Immunol."},{"key":"10.1016\/j.heliyon.2024.e37896_bib32","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.4049\/jimmunol.168.12.6208","article-title":"KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential","volume":"168","author":"Faure","year":"1950","journal-title":"Journal of immunology (Baltimore, Md"},{"key":"10.1016\/j.heliyon.2024.e37896_bib33","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1111\/cas.15499","article-title":"Clinical significance and immune landscape of KIR2DL4 and the senescence-based signature in cutaneous melanoma","volume":"113","author":"Mao","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.heliyon.2024.e37896_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jnci\/djad247","article-title":"Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers","volume":"116","author":"Sun","year":"2024","journal-title":"J. Natl. Cancer Inst. (Bethesda)"},{"key":"10.1016\/j.heliyon.2024.e37896_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/2159-8290.CD-23-0530","article-title":"Cancer evolution: a multifaceted affair","volume":"14","author":"Ciriello","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.heliyon.2024.e37896_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2024.e37896_bib37","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1158\/2159-8290.CD-20-1503","article-title":"Synthetic lethality in cancer therapeutics: the next generation","volume":"11","author":"Setton","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.heliyon.2024.e37896_bib38","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","article-title":"An integrated tumor, immune and microbiome atlas of colon cancer","volume":"29","author":"Roelands","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e37896_bib39","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1136\/gutjnl-2019-320105","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8(+) T cells in mice","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2024.e37896_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188775","article-title":"Anti-PD-1 combined with targeted therapy: theory and practice in gastric and colorectal cancer","volume":"1877","author":"Chen","year":"2022","journal-title":"Biochim. Biophys. Acta, Rev. Cancer"},{"key":"10.1016\/j.heliyon.2024.e37896_bib41","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/bjs\/znab342","article-title":"Neoadjuvant immunotherapy in primary and metastatic colorectal cancer","volume":"108","author":"Kanani","year":"2021","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.heliyon.2024.e37896_bib42","first-page":"306","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer, Nature reviews","volume":"20","author":"Bando","year":"2023","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e37896_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101948","article-title":"Adjuvant chemotherapy for rectal cancer: current evidence and recommendations for clinical practice","volume":"83","author":"Bregni","year":"2020","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.heliyon.2024.e37896_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102676","article-title":"Neoadjuvant chemotherapy for early-stage colon cancer","volume":"123","author":"Audisio","year":"2024","journal-title":"Cancer Treat Rev."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024139278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024139278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:49:54Z","timestamp":1790714994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024139278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":44,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2405844024139278"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37896","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated bioinformatics analysis and validation identify KIR2DL4 as a novel biomarker for predicting chemotherapy resistance and prognosis in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37896","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e37896"}}